chronic obstructive pulmonary disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. The diagnosis of chronic obstructive pulmonary disease complies with the disease diagnosis and treatment guidelines formulated by the Respiratory Disease Branch of the Chinese Medical Association; 2. Disease duration <= 1 year; 3. Assessment of medication compliance<6 points; 4. Patients have communication skills and can independently or with the assistance of researchers fill out the required research questionnaire; 5. Have used at least one dry powder inhaler in the past (such as salmeterol, fluticasone powder, budesonide, formoterol powder, tiotropium bromide powder, etc.); 6. Non solitary patients; 7. Having a smartphone, able to access the internet and use apps on the phone; 8. Patient and his/her caregiver agree to cooperate with the relevant requirements of the research plan and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Suffering from diseases such as bronchial asthma, bronchiectasis, tuberculosis damaged lungs, and thoracic deformities; 2. Individuals with severe mental illness or intellectual disability; 3. Individuals with unclear consciousness or communication barriers; 4. Those who do not agree to cooperate with the research or request termination; 5. Patients who participated in other studies that affected the implementation and accuracy of the results of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Qualified compliance rate for inhalation drug therapy; | — |
Secondary
| Measure | Time frame |
|---|---|
| Acute exacerbation rate of chronic obstructive pulmonary disease;Changes in cardiopulmonary function;Respiratory Difficulty Scale Score;Disease control evaluation; | — |
Countries
China
Contacts
Beijing Chaoyang Hospital Affiliated to Capital Medical University